Brain Health Product development in vivo models
2017/10/09Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide–induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer’s disease suggested
2018/02/19Amylgen’s murine model demonstrates the efficacy of RegenLife ’s device application for the treatment of Alzheimer’s disease
Regenlife is opening doors to new treatment options for Alzheimer’s disease.
Read the original article here.